HUMAN PAPILLOMAVIRUS (HPV) - ANVISA Registration 10322250019

Access comprehensive regulatory information for HUMAN PAPILLOMAVIRUS (HPV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10322250019 and manufactured by QIAGEN. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until Oct 04, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including GENOMICA S.A.U., MOBIUS LIFE SCIENCE INDÚSTRIA E COMERCIO DE PRODUTOS PARA LABORATÓRIOS LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.